BioAge Labs, Inc.
BIOA
$4.38
$0.153.55%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -- | -- | |
| Cost of Revenue | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | |
| SG&A Expenses | 32.00% | -- | -- | -- | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 61.56% | -- | -- | -- | |
| Operating Income | -61.56% | -- | -- | -- | |
| Income Before Tax | -11.36% | -- | -- | -- | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -11.36% | -- | -- | -- | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -11.36% | -- | -- | -- | |
| EBIT | -61.56% | -- | -- | -- | |
| EBITDA | -61.75% | -- | -- | -- | |
| EPS Basic | 39.78% | -- | -- | -- | |
| Normalized Basic EPS | 28.94% | -- | -- | -- | |
| EPS Diluted | 39.78% | -- | -- | -- | |
| Normalized Diluted EPS | 28.94% | -- | -- | -- | |
| Average Basic Shares Outstanding | 541.04% | -- | -- | -- | |
| Average Diluted Shares Outstanding | 541.04% | -- | -- | -- | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |